DOCSLIB.ORG

Original Article Anti-Allodynia Effect of Safranal on Neuropathic Pain Induced by Spinal Nerve Transection in Rat

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Original Article Anti-Allodynia Effect of Safranal on Neuropathic Pain Induced by Spinal Nerve Transection in Rat Int J Clin Exp Med 2014;7(12):4990-4996 www.ijcem.com /ISSN:1940-5901/IJCEM0002918 Original Article Anti-allodynia effect of safranal on neuropathic pain induced by spinal nerve transection in rat Ke-Jun Zhu, Ji-Shun Yang Department of Trauma Surgery, The 100th Hospital of PLA, Suzhou 215007, Jiangsu Province, China Received October 1, 2014; Accepted December 8, 2014; Epub December 15, 2014; Published December 30, 2014 Abstract: In this study, we investigated the anti-allodynia effect of safranal, the main volatile constitute of saffron, in spinal nerve transection model of rats. Meanwhile, to elucidate the mechanism, we determined the dynamic expression changes of glial activation markers (GFAP and OX-42) and inflammatory cytokines (TNF-α and IL-1β) in ipsilateral dorsal horn of lumbar enlargement post surgery. Results showed significant increase of these markers along with development of mechanical allodynia. Safranal (0.1 mg/kg, i.p.) attenuated the pain sensitivity and inhib- ited the expression of these markers. The results demonstrate that the antiallodynia effect of safranal after nerve injury might be attributed to its inhibiting effect on glial activation and inflammatory cytokine production in central nervous system. Keywords: Safranal, anti-allodynia, glial activation, pro-inflammatory cytokines, spinal nerve transection Introduction ranal has yet been elucidated. Moreover, no study has been reported to reveal the underly- Safranal (Figure 1) is the main volatile fraction ing mechanism of the antiallodynia mechanism of Crocus sativus L. (commonly known as saf- of safranal under neuropathic pain conditions. fron) [1], which has been widely used for pain relief and other ailments including broncho- It has been suggested that inflammatory and spasm, asthma and cardiovascular diseases in immune mechanisms play key roles in neuro- traditional medicine of Iran, India, Greece and pathic pain [16]. In response to nerve damage, other countries [2-4]. The main active constitu- infiltration of inflammatory cells and activation ents of saffron include carotenoid pigments of resident immune cells may lead to the pro- called tricrocin, bicrocin and crocin, a bitter gly- duction and secretion of inflammatory cyto- coside called picocrocin, and safranal [5]. kines, which may in turn activate the neuroim- Ethanolic and aqueous extract of saffron and mune response and sensitize the primary sen- crocin showed anti-allodynia and anti-inflam- sory neurons and contribute to neuropathic matory effects in different animal models pain [17, 18]. Inflammatory cytokines such as [6-10]. As the main volatile constitution of saf- IL-1, TNF-α and IL-6 [16], as well as immune-like fron, safranal has also been demonstrated glia cells including microglia and astrocytes [19, antiallodynia effect in the formalin, acetic acid 20] have been implicated in the development of or carrageenan induced acute pain, and sciatic neuropathic pain. chronic constriction induced neuropathic pain [11, 12]. Besides the antiallodynia effect, phar- In this study, we investigated the antiallodynia macological studies have suggested the anti- effect of safranal in a model of neuropathic oxidative, anti-inflammatory, anti-cancer and pain induced by spinal nerve transection (SNT) tissue protective effects of safranal [10, 13]. in rat. Meanwhile, we detected the expression changes of glial activation markers (GFAP and Though some study suggested the role of its OX-42) and inflammatory cytokines (TNF-α and anti-inflammatory and anti-oxidative activities IL-1β) in the ipsilateral dorsal horn of lumbar [14, 15], the anti-allodynia mechanism of saf- enlargement. The results suggested that the Anti-allodynia effect of safranal nal nerve was selectively transected leaving the L4 spinal nerve untouched. The wound was irrigated with saline and closed in two layers with 3-0 suture. Animals in the sham group underwent the sham operation without injuring the spinal nerve. After surgery, animals were administered drugs immediately. Drugs were administered daily for 21 consecutive days. Animals in sham group were administered with saline (2 ml/kg, i.p.). Behavior study Mechanical sensitivity of rats was tested with Figure 1. Chemical structure of Safranal. von Frey filaments on two consecutive days before surgery and 1, 7, 21 days post surgery. antiallodynia effect of safranal may, at least in Animals were placed on an elevated steel mesh part, be attributed to its inhibition of glial acti- with a translucent plexiglass cover, and an vation and inflammatory cytokine production in adaptation of 30 min was permitted. The test the nervous system. procedure was followed the up-and-down method of Dixon [21]. A series of filament were Materials and methods presented to the sural nerve innervated area in the plantar surface of the injury-side hind paw. Animals and drugs At least one robust paw lift occurred in every two stimuli was recorded as a positive reaction. Male SD rats with initial weight of 160-180 g When a positive reaction occurred, a higher fila- were purchased from Animal center of Beijing ment was used; otherwise, a lower filament institute of pharmacology and toxicology. Rats was used. After the appearance of positive/ were housed in an environment of 12 h light/ negative cross, another four stimuli were pre- dark cycle with freedom to food and water. sented. The fifty percent threshold was calcu- lated following the formula given by Dixon [21]. Safranal was obtained from Sigma-Aldrich Chemical Co. (St. Louis, MO, USA) and diluted in Tissue collection saline before use [7]. The purity of safranal was confirmed to be > 99% by 1H-NMR analysis. After anesthesia with phenobarbital sodium, Propentofylline (purity > 98%) was purchased animals were sacrificed by decapitation. A seg- from Carbone Scientific Co., LTD (London, ment of vertebral column including the lumbar United Kingdom) and diluted in saline before enlargement was cut off. The spinal cord seg- use. ment was pushed out by compressed saline from an injector manually. The dorsal horn of Spinal nerve transection and drug administra- the lumbar enlargement was removed and the tion ipsilateral and contralateral sides were sepa- rated. The dorsal horn samples were stored at Sixty male SD rats were randomly divided into -70°C for real-time PCR and western blot four groups: the sham group, vehicle group (2 analysis. ml/kg, i.p.), propentofylline group (10 mg/kg, i.p.) and safranal (0.1 mg/kg, i.p.) group [7]. RNA extraction and real-time PCR Rats were anesthetized with sodium pentobar- bital (40 mg/kg, i.p.). A small incision to the Total RNA was extracted from dorsal horn of skin overlying L5-S1 was made and the para- lumbar enlargement with TRIzol regent follow- vertebral musculature was retracted from the ing the protocol given by the producer vertebral transverse processes. By partially (Invitrogen, Burlington, Canada). RNA integrity removing the L6 transverse process, the L4 was checked in agarose gel electrophoresis. and L5 spinal nerves were exposed. The L5 spi- The reverse transcription was carried out with 4991 Int J Clin Exp Med 2014;7(12):4990-4996 Anti-allodynia effect of safranal min at room temperature. Then the membrane was incubated at 4°C overnight with a rabbit polyclonal anti-OX42 (1:300, Novus Biologi- cals, Inc), or a rabbit polyclonal anti-GFAP antibody (1:5000, Novus Biologicals, Inc), or a mouse mono- clonal anti-beta-actin antibody (1:3000, Sigma Aldrich). Then the membrane were washed with TBS containing 0.1% Tween-20 three times of 10 min and incubated in the secondary antibodies conjugat- Figure 2. Development of mechanical allodynia post SNT surgery. Sig- nificant decrease of mechanical withdrawal threshold of model animals ed with horseradish peroxidase in vehicle group was observed throughout the observation period. Both (1:2000, Vector) for 1 h at room propentofylline (10 mg/kg, i.p.) and safranal (0.1 mg/kg, i.p.) inhibited temperature. After three times the development of mechanical allodynia at 7 and 21 d post surgery. washes of 10 min, the immunore- $$$P < 0.001, compared to sham group; **P < 0.01, ***P < 0.001, #P active proteins were detected with < 0.05, compared to vehicle group. enhanced chemiluminescence (Am- ersham Biosciences, Arlington Hei- 1 μg of RNA sample under catalysis of M-MLV ghts, IL, USA), and the signal were captured by reverse transcriptase (Invitrogen, Burlington, a Fujifilm LAS-1000 imager system. Quanti- Canada). Real-time PCR was carried out in a 20 fication of the proteins was performed using μL reaction mixture containing 10 μL 2* SYBR the ImageJ software with beta-actin as the Green Master Mix (PE, Biosystems), 2 μL cDNA inner control. solution, 4 μM forward and reverse primers in a ABI Prism 7500 system (PE, Applied Biosystems, Statistical analysis Foster City, CA). The reaction procedure con- All data was expressed as mean ± SEM. Data sists of a pre-incubation of 10 min at 95°C fol- were analyzed with two-way analysis of vari- lowed by 40 cycles at 95°C for 15 sec and ance, followed by Bonferroni post hoc test. 60°C for 1 min. The relative mRNA content of Difference with P value lower than 0.05 was target genes were calculated by 2-ΔΔCt with accepted as significant. β-actin as the inner control. The primers used were as follows: GFAP: forward, 5’-TGGCCAC- Results CAGTAACATGCAA-3’, reverse, 5’-CAGTTGGCGG- CGATAGTCAT-3’; OX-42: forward, 5’-CTGCCTCA- Effects of safranal and propentofylline on me- GGGATCCGTAAAG-3’, reverse, 5’-CCTCTGCCTC- chanical allodynia induced by SNT AGGAATGACATC-3’ [22]; TNF-α: forward, 5’-TG- CCTCAGCCTCTTCTCATTC-3’, reverse, 5’-GCTCC- SNI surgery induced significant mechanical TTCTGCTTGGTGGTTT-3’; IL-1β: forward, 5’-GC- allodynia of the injured paw. Across the obser- ACCTTCTTTTCCTTCATCTTTG-3’, reverse, 5’-TTT- vation period, the mechanical withdrawal GTCGTTGCTTGTCTCTCCTT-3’ [23]. threshold of the model group was significantly lower than the sham group, while both propen- Protein extraction and western blot tofylline and safranal significantly attenuated the reduction of the mechanical withdrawal To prepare the protein from dorsal horn of the threshold at 7 and 21 days post surgery (Figure lumbar enlargement, the tissue samples were 2).
Load more

Recommended publications
  • Safranal, a Saffron Constituent, Attenuates Retinal Degeneration in P23H Rats
    Safranal, a Saffron Constituent, Attenuates Retinal Degeneration in P23H Rats Laura Ferna´ndez-Sa´nchez1., Pedro Lax1., Gema Esquiva1, Jose´ Martı´n-Nieto1, Isabel Pinilla2, Nicola´s Cuenca1* 1 Department of Physiology, Genetics and Microbiology, University of Alicante, Alicante, Spain, 2 Department of Ophthalmology, University Hospital Lozano Blesa, Zaragoza, Spain Abstract Saffron, an extract from Crocus sativus, has been largely used in traditional medicine for its antiapoptotic and anticarcinogenic properties. In this work, we investigate the effects of safranal, a component of saffron stigmas, in attenuating retinal degeneration in the P23H rat model of autosomal dominant retinitis pigmentosa. We demonstrate that administration of safranal to homozygous P23H line-3 rats preserves both photoreceptor morphology and number. Electroretinographic recordings showed higher a- and b-wave amplitudes under both photopic and scotopic conditions in safranal-treated versus non-treated animals. Furthermore, the capillary network in safranal-treated animals was preserved, unlike that found in untreated animals. Our findings indicate that dietary supplementation with safranal slows photoreceptor cell degeneration and ameliorates the loss of retinal function and vascular network disruption in P23H rats. This work also suggests that safranal could be potentially useful to retard retinal degeneration in patients with retinitis pigmentosa. Citation: Ferna´ndez-Sa´nchez L, Lax P, Esquiva G, Martı´n-Nieto J, Pinilla I, et al. (2012) Safranal, a Saffron Constituent, Attenuates Retinal Degeneration in P23H Rats. PLoS ONE 7(8): e43074. doi:10.1371/journal.pone.0043074 Editor: Alfred Lewin, University of Florida, United States of America Received May 3, 2012; Accepted July 16, 2012; Published August 10, 2012 Copyright: ß 2012 Ferna´ndez-Sa´nchez et al.
    [Show full text]
  • Determinación Técnica Analitos LC
    AGROALIMENTARIO 201 8 LISTADO DE DETERMINACIONES Determinación Técnica Analitos LC Butyric Acid, Hexanoic Acid, Octanoic Acid, Decanoic Acid, Undecanoic Acid, Lauric Acid, Tridecanoic Acid, Myristic Acid, Myristoleic Acid, Pentadecanoic Acid, cis-10-pentadecenoic Acid, Palmitic Acid, Palmitoleic Acid, Heptadecanoic Acid, cis-10-Heptadecanoic Acid, Stearic Acid, trans-9-Elaidic Acid, cis-9- Oleic Acid, linolelaidic Acid, linoleic Acid, arachidic Acid, γ-linolenic Acid, eicosenoic Acid, linolenic Acid, Ácidos Grasos GC 0,10 % heneicosanoic Acid, cis-11,14-Eicosadienoic Acid, Behenic Acid, cis-8,11,14-Eicosatrienoic Acid, Erucic Acid, cis-11,14,17-Eicosatrienoic Acid, cis-5,8,11,14-Eicosatetraenoic Acid, Tricosenoic Acid, cis-13,16- Docosadienoic Acid, Lignoceroic Acid, cis-5,8,11,14,17-Eicosapentaenoic Acid, Nervonic Acid, cis- 4,7,10,13,16,19-Docosahexaenoic Acid, cis-4,7,10,13,16,19-Docosahexaenoic Acid Ácidos Grasos cis-trans GC/MS omega3, omega 6 o DHA y omega 9 0,10 % Ác. Acético, Ác. Ascórbico, Ác.Butírico, Ác. Benzoico, Ác. Cítrico, Ác. Fórmico, Ác. Propiónico, Ác. Ácidos Orgánicos HPLC 10 mg/kg Salicílico, Ác. Sórbico, Ác. Shikímico, Ác. Valérico, Ác. Iso-Valérico, Ác. Hexanoico, Ac. Gluconico Ácidos Orgánicos LC/MS/MS Ac. Gluconico 0.05 g/L Acrilamida LC/MS/MS Acrilamida 1 µg/kg Aflatoxinas LC/MS/MS Aflatoxin B1, Aflatoxin B2, Aflatoxin G1, Aflatoxin G2 1 µg/kg Alcoholes GC 1-Butanol, Ethanol, Hexanol, Isobutanol, Isopropanol, Methanol, Propanol 1 mg/kg Aldehídos GC Formaldehyde, Acetaldehyde, Propanal, Butanal, Furfural 0.1 mg/kg
    [Show full text]
  • Putting a Pause on Pelvic Pain: Nutrition and Supplemental Highlights
    PUTTING A PAUSE ON PELVIC PAIN: NUTRITION AND SUPPLEMENTAL HIGHLIGHTS Lise Alschuler, ND NHAND 2020 DISCLOSURES • Has received compensation for occasional industry-sponsored webinars and educational presentations: • 2020: NutraBioceuticals, Gaia • Co-principal for Thrivers, LLC, an educational company that hosts a weekly health and wellness radio show for consumers and which receives industry sponsorship • 2020: Kyowa Hakko, Dr Ohhria Probiotics, Hyatt Life Sciences • Has received research funding: • Pharmavite (2020) 2 TOPICS • Quick overview of chronic pelvic pain pathways relevant to modification by nutrition and dietary supplements. • Gain familiarity with core dietary approaches with evidence of pain modification effects. • Explore the evidence for specific dietary supplements which may modify chronic pelvic pain. 3 PELVIC PAIN: CENTRALIZED PAIN • Chronic pelvic pain (continuous or intermittent pain x 3-6 months) affects 1 in 5 reproductive aged women. • Pelvic pathology does not necessarily correlate with degree of pelvic pain. • Central pain amplification is a component of chronic pelvic pain resulting in generalized heightened pain sensitivity (hyperalgesia) • Begins with persistent peripheral nociception (most commonly from inflammation or lesions) leading to: • Hyperresponsiveness of dorsal horn spinal neurons via N-methyl-D-aspartic (NMDA) receptors - and / or - • Upregulated nociceptive processing within the brain (catastrophizing) • Evidence of pain centralization in women with chronic pelvic pain is high prevalence of co-morbid conditions: • headaches are found in over 50% • IBS, vulvodynia and/or chronic fatigue syndrome are found in 20% As-Sanie E, et al. Obstetrics and Gynecol. 2013;122(5):1047 4 PAIN CENTRALIZATION IS AFFECTED BY MULTIPLE FACTORS • Peripheral tissue injury or lesion leads to increased NGF and inflammatory mediators (ie TNF�) which cause increased sensory nerve growth and sensitization.
    [Show full text]
  • Preliminary Phytochemical Analysis and Antioxidant, Antibacterial
    Available online: www.notulaebotanicae.ro Print ISSN 0255-965X; Electronic 1842-4309 Not Bot Horti Agrobo , 2015, 43(2):343 -348 . DOI:10.15835/nbha43210089 Preliminary Phytochemical Analysis and Antioxidant, Antibacterial Activities of Crocus alatavicus from Kazakhstan Dariya SATYBALDIYEVA 1*, Valentina MURSALIYEVA 2, Izbassar RAKHIMBAYEV 2, Bolatkhan ZAYADAN 1, Ramazan MAMMADOV 3 1Al-Farabi Kazakh National University, Faculty of Biology and Biotechnology, Al-Farabi 71/6, Almaty 050040, Kazakhstan; [email protected] (*corresponding author); [email protected] 2Institute of Plant Biology and Biotechnology, Laboratory of Clonal Propagation, Timiryazev 45, Almaty 050040, Kazakhstan; [email protected] ; [email protected] 3Pamukkale University, Faculty of Science and Letters, Kinikli 20017, Denizli, Turkey; [email protected] Abstract Phytochemical analysis of C. alatavicus revealed the presence of phenols, flavonoids, anthocyanins, carotenoids, amino acids and carbohydrates. The flavonoid, amino acids and carotenoid contents were higher in aerial part (1.50%, 7.49% and 9.78 mg%, respectively) than in bulb (0.43%, 3.88% and 0.91 mg%, respectively). Total phenolic content (TPC), total antioxidant (TAA), 2.2-diphenyl-1-picrylhydrazyl (DPPH) radical scavenging and antibacterial activities of water, methanol, ethanol and dichloromethane extracts from aerial part and bulb were tested. TPC ranged from 13.63 to 72.29 mg gallic acid equivalents (GAE)/g extract. The maximum TAA were observed in ethanol (61.34%) and methanol extracts (46.13%) from aerial part with a high TPC (72.29 and 62.37 mgGAE/g extract, respectively). Ethanol extracts from aerial part and bulb had good scavenger of DPPH radicals (65.5% and 54.08%, respectively) with an IC 50 387 and 447 µg/ml.
    [Show full text]
  • Effect of Oral Saffron Capsules on Sleep Quality in Patients with Diabetes at Zabol-Iran, Bali Medical Journal 6(3): 595-600
    ORIGINAL ARTICLE Bali Medical Journal (Bali Med J) 2017, Volume 6, Number 3: 595-600 P-ISSN.2089-1180, E-ISSN.2302-2914 Effect of oral saffron capsules on sleep quality in ORIGINAL ARTICLE patients with diabetes at Zabol-Iran CrossMark Doi: http://dx.doi.org/10.15562/bmj.v6i3.623 Sadegh Dehghanmehr,1 Hossein Shadadi,2* Ali Mansouri,2 Azizollah Arbabisarjou3 Published by DiscoverSys Volume No.: 6 ABSTRACT Introduction: People with diabetes have delayed sleep compared group and a placebo capsule in the control group, for a week, every day to ordinary people and do not have good sleep quality because between hours 12 to 14 am and after taking lunch. After a week, sleep Issue: 3 of impaired glucose level. Saffron effect on insomnia in several quality measured again. studies on animals have checked, and beneficial results for it have Results: After the intervention, the comparison of the mean scores observed. of two groups showed a significant difference (P = 0.001). Also, Methods: This study was a quasi-experimental study aiming comparison of a total mean score of sleep quality in patients before First page No.: 595 to determine the effect of oral saffron capsules on sleep quality and after intervention showed statistically significant difference in in diabetic patients in the city of Zabol in 2016. This study conducted two groups (p = 0.001). on 50 diabetic patients in Zabol city which were qualified for inclusion Conclusion: Results of this study showed that daily administration P-ISSN.2089-1180 criteria for the study. The sleep quality of patients assessed with of saffron oral capsules improves sleep quality in diabetic patients.
    [Show full text]
  • Herbs for Neurology in Restorative Medicine
    Herbs for Neurology in Restorative Medicine Kevin Spelman, PhD, MCPP Health, Education & Research in Botanical Medicine Financial Disclosure •Consultant for Restorative Formulations •I have been a Natural Products and Cannabis Industry Consultant, for GMPs, Regulatory Issues, Pharmacology, Research Initiatives, New Product Development and Formulation •I have financial interests in the Natural Products Industry The Herbs Phytochemistry is Key Botanical Neuro MOAs • Botanical Medicines may alter neurotransmitter binding and uptake, synthesis, and regulation or supporting healthy function of the endocrine system. • Modulation of neuronal communication – Via specific plant metabolites binding to neurotransmitter/neuromodulator receptors – Via alteration of neurotransmitter synthesis, breakdown and function • Stimulating or sedating CNS activity • Regulating and supporting the healthy function of the endocrine system • Providing increased adaptation to exogenous stressors (adaptogenic/tonic effects • Epigenetic alteration, for example, Hypericum perforatum modulates similar genetic expressions to a conventional antidepressant Sarris J, Panossian A. Schweitzer I, Stough C, Scholey A. Herbal medicine for depression, anxiety and insomnia: A review of psychopharmacology and clinical evidence. Eur Neuropsychopharmacol. 2011 Dec;21(12):841-60 Neuro MOAs In Botanicals “more sophisticated neuropharmacologic techniques of the future will reveal novel and marvelously subtle pharmacologic activities for herbal medicines that current research methods fail
    [Show full text]
  • B COMMISSION DECISION of 23 February 1999 Adopting a Register
    1999D0217 — EN — 27.02.2009 — 007.001 — 1 This document is meant purely as a documentation tool and the institutions do not assume any liability for its contents ►B COMMISSION DECISION of 23 February 1999 adopting a register of flavouring substances used in or on foodstuffs drawn up in application of Regulation (EC) No 2232/96 of the European Parliament and of the Council of 28 October 1996 (notified under number C(1999) 399) (text with EEA relevance) (1999/217/EC) (OJ L 84, 27.3.1999, p. 1) Amended by: Official Journal No page date ►M1 Commission Decision 2000/489/EC of 18 July 2000 L 197 53 3.8.2000 ►M2 Commission Decision 2002/113/EC of 23 January 2002 L 49 1 20.2.2002 ►M3 Commission Decision 2004/357/EC of 7 April 2004 L 113 28 20.4.2004 ►M4 Commission Decision 2005/389/EC of 18 May 2005 L 128 73 21.5.2005 ►M5 Commission Decision 2006/252/EC of 27 March 2006 L 91 48 29.3.2006 ►M6 Commission Decision 2008/478/EC of 17 June 2008 L 163 42 24.6.2008 ►M7 Commission Decision 2009/163/EC of 26 February 2009 L 55 41 27.2.2009 1999D0217 — EN — 27.02.2009 — 007.001 — 2 ▼B COMMISSION DECISION of 23 February 1999 adopting a register of flavouring substances used in or on foodstuffs drawn up in application of Regulation (EC) No 2232/96 of the European Parliament and of the Council of 28 October 1996 (notified under number C(1999) 399) (text with EEA relevance) (1999/217/EC) THE COMMISSION OF THE EUROPEAN COMMUNITIES, Having regard to the Treaty establishing the European Community, Having regard to Regulation (EC) No 2232/96 of the European Parliament
    [Show full text]
  • Safranal Treatment Improves Hyperglycemia, Hyperlipidemia and Oxidative Stress in Streptozotocin-Induced Diabetic Rats
    J Pharm Pharm Sci (www.cspsCanada.org) 16(2) 352 - 362, 2013 Safranal Treatment Improves Hyperglycemia, Hyperlipidemia and Oxidative Stress in Streptozotocin-Induced Diabetic Rats Saeed Samarghandian1, 2, Abasalt Borji1, 2, Mohammad Bagher Delkhosh2, Fariborz Samini3 1Department of Basic Medical Sciences, Neyshabur University of Medical Sciences, Neyshabur, Iran. 2Health Strategic Research Center, Neyshabur University of Medical Sciences, Neyshabur, Iran. 3Neurosurgery Department, Faculty of Science, Mashhad University of Medical Sciences, Mashhad, Iran Received, March 8, 2013; Accepted, July 24, 2013; Published, August 2, 2013. ABSTRACT - Purpose. Clinical research has confirmed the efficacy of several plant extracts in the modulation of oxidative stress associated with diabetes mellitus. Findings indicate that safranal has antioxidant properties. The aim of the present study was the evaluation of possible protective effects of safranal against oxidative damage in diabetic rats. Methods. In this study, the rats were divided into the following groups of 8 animals each: control, untreated diabetic, three safranal (0.25, 0.50, 0.75 mg/kg/day)-treated diabetic groups. Diabetes was induced by streptozotocin (STZ) in rats. STZ was injected intraperitoneally at a single dose of 60 mg/kg for diabetes induction. Safranal (intraperitoneal injection) was administered 3 days after STZ administration; these injections were continued to the end of the study (4 weeks). At the end of the 4-week period, blood was drawn for biochemical assays. In order to determine the changes of cellular antioxidant defense systems, antioxidant enzymes including glutathione peroxidase (GSHPx), superoxide dismutase (SOD) and catalase (CAT) activities were measured in serum. Moreover we also measured serum nitric oxide (NO) and serum malondialdehyde (MDA) levels, a marker of lipid peroxidation.
    [Show full text]
  • Crocus Sativus L. Extracts and Its Constituents Crocins and Safranal; Potential Candidates for Schizophrenia Treatment?
    molecules Review Crocus sativus L. Extracts and Its Constituents Crocins and Safranal; Potential Candidates for Schizophrenia Treatment? Nikolaos Pitsikas Department of Pharmacology, School of Medicine, Faculty of Health Sciences, University of Thessaly, Biopolis, Panepistimiou 3, 415-00 Larissa, Greece; [email protected]; Tel.: +30-2410-685-535 Abstract: Schizophrenia is a chronic mental devastating disease. Current therapy suffers from various limitations including low efficacy and serious side effects. Thus, there is an urgent necessity to develop new antipsychotics with higher efficacy and safety. The dried stigma of the plant Crocus sativus L., (CS) commonly known as saffron, are used in traditional medicine for various purposes. It has been demonstrated that saffron and its bioactive components crocins and safranal exert a beneficial action in different pathologies of the central nervous system such as anxiety, depression, epilepsy and memory problems. Recently, their role as potential antipsychotic agents is under investigation. In the present review, I intended to critically assess advances in research of these molecules for the treatment of schizophrenia, comment on their advantages over currently used neuroleptics as well-remaining challenges. Up to our days, few preclinical studies have been conducted to this end. In spite of it, results are encouraging and strongly corroborate that additional research is mandatory aiming to definitively establish a role for saffron and its bioactive components for the treatment of schizophrenia. Keywords: Crocus sativus L.; crocins; schizophrenia Citation: Pitsikas, N. Crocus sativus L. Extracts and Its Constituents Crocins and Safranal; Potential Candidates for 1. Schizophrenia Schizophrenia Treatment? Molecules Schizophrenia is a serious chronic mental disease that affects up to 1% of the world 2021, 26, 1237.
    [Show full text]
  • The Relaxant Activity of Safranal in Isolated Rat Aortas Is Mediated Predominantly Via an Endothelium-Independent Mechanism - Vasodilatory Mechanism of Safranal
    ISSN 2093-6966 [Print], ISSN 2234-6856 [Online] Journal of Pharmacopuncture 2016;19[4]:329-335 DOI: https://doi.org/10.3831/KPI.2016.19.034 Original article The Relaxant Activity of Safranal in Isolated Rat Aortas is Mediated Predominantly via an Endothelium-Independent Mechanism - Vasodilatory mechanism of safranal - Bibi Marjan Razavi1, Mojtaba Alipoor Amanloo2, Mohsen Imenshahidi3, Hossein Hosseinzadeh3* 1Targeted Drug Delivery Research Center, Department of Pharmacodynamics and Toxicology, School of Pharmacy, Mashhad University of Medical Sciences, Mashhad, Iran 2 School of Pharmacy, Mashhad University of Medical Sciences, Mashhad, Iran 3 Pharmaceutical Research Center, Department of Pharmacodynamy and Toxicology, School of Pharmacy, Mashhad University of Medical Sciences, Mashhad, Iran Key Words Results: Safranal induced relaxation in endotheli- um-intact aortic rings precontracted by using PE or aorta ring, indomethacin, L-NAME, saffron, KCl in a concentration-dependent manner, with a vasodilatory effect maximum relaxation of more than 100%. The relaxant activity of safranal was not eliminated by incubating Abstract the aortic rings with L-NAME (EC50 = 0.29 vs. EC50 = 0.43) or with indomethacin (EC50 = 0.29 vs. EC50 = 0.35), Objectives: Safranal is a pharmacologically active com- where EC50 is the half maximal effective concentration. ponent of saffron and is responsible for the unique aro- Also, the vasodilatory activity of safranal was not mod- ma of saffron. The hypotensive effect of safranal has ified by endothelial removal. been shown in previous studies. This study evaluates the mechanism for the vasodilatory effects induced by Conclusion: This study indicated that relaxant activity safranal on isolated rat aortas. of safranal is mediated predominantly through an en- dothelium-independent mechanism.
    [Show full text]
  • Evidence Based Herbal Medicine and Mental Health
    Journal of Medicinal Plants Evidence Based Herbal Medicine and Mental Health Hajiaghaee R (Ph.D.)1, Akhondzadeh S (Ph.D.)2* 1- Pharmacognosy & Pharmaceutics Department of Medicinal Plants Research Center, Institute of Medicinal Plants, ACECR, Karaj, Iran 2- Psychiatric Research Center, Roozbeh Hospital, Tehran University of Medical Sciences, Tehran, Iran * Corresponding author: Psychiatric Research Center, Roozbeh Hospital, South Kargar Street, Tehran 13337, Iran Tel: +98-21-88281866, Fax: +98-21-55419113 Email: [email protected] Received: 21 Aug. 2012 Accepted: 16 Nov. 2012 Abstract Many cultures have developed folk herbal remedies for various symptoms of mental illness. An evidence base now is being developed for some of these “alternative” herbal remedies. There has been an increase in the number and proportion of clinical trials of complementary medicine, which suggests a trend toward an evidence-based approach. This review presents the scientific information regarding herbal medicine with evidence based approaches for saffron. Keywords: Crocus sativus, Evidence Based Herbal Medicine, Mental health 1 1 Volume 11, No. 43, Summer 2012 Evidence Based Herbal … Introduction and available in hospitals. Nevertheless, many Complementary medicine are interventions people using herbal medicines find the health that are not widely taught in medical schools care alternatives are more congruent with their and are not part of the usual arsenal of own values, beliefs and philosophical treatments and medications recommended and orientations toward health and life. Similarly, prescribed by physicians and available in it seems likely that many people feel that hospitals. Use of Complementary medicine is herbal medicines are empowering by allowing dependent, not on dissatisfaction with them to treat themselves without seeing a conventional medicine as it is most commonly physician.
    [Show full text]
  • Mini Review: SEDATIVE and HYPNOTIC EFFECTS of IRANIAN
    EXCLI Journal 2011;10:192-197 – ISSN 1611-2156 Received: August 31, 2011, accepted: October 03, 2011, published: October 10, 2011 Mini review: SEDATIVE AND HYPNOTIC EFFECTS OF IRANIAN TRADITIONAL MEDICINAL HERBS USED FOR TREATMENT OF INSOMNIA Sasan Andalib1, Ali Vaseghi2, Golnaz Vaseghi3,*, Azadeh Motavallian Naeini3 1 School of Veterinary Medicine, Islamic Azad University of Tabriz, Tabriz, Iran 2 Department of General Sciences, Capilano University, Vancouver, BC, Canada 3 Department of Pharmacology, School of Pharmacy and Pharmaceutical Sciences, Isfahan University of Medical Sciences, Isfahan, Iran * corresponding author: email: [email protected]; Contact No.: +983117922628; Fax: +983116680011 ABSTRACT For tens of centuries, plants have been highly valued and regularly used as medicine amongst the masses. Insomnia, a loss of sleep, is mostly treated by synthetic sleeping tablets these days. However, questions have been raised about the safety of prolonged use of artificial sedatives due to their deleterious side effects such as physical dependence. In recent years, there has been an increasing propensity to preclude insomnia by herbal medicines throughout the world. Many herbs have a lengthy background in terms of insomnia treatment in Iran. This paper gives an account of previously published research on sedative and hypnotic effects of medicinal herbs used for treatment of insomnia in Iranian traditional medicine. Keywords: Iranian medicinal herbs, Iranian traditional medicine, insomnia, sedative effect, hypnotic effect INTRODUCTION cines. Some insomniacs rely on sleeping tablets such as benzodiazepines and newer Nowadays, insomnia has been a con- nonbenzodiazepines to get rest (Smith and spicuous problem or disease in our restless Tett, 2010; Richey and Krystal, 2011). De- society.
    [Show full text]